References analysis of the Wikipedia article "Receptor da insulina" in the Galician version

doi.org

dx.doi.org

Ward CW, Lawrence MC (abril de 2009). "Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor". BioEssays 31 (4): 422–34. PMID 19274663. doi:10.1002/bies.200800210.

Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Clauser E, Ou JH, Masiarz F, Kan YW, Goldfine ID (abril de 1985). "The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling". Cell 40 (4): 747–58. PMID 2859121. doi:10.1016/0092-8674(85)90334-4.

Malaguarnera R, Sacco A, Voci C, Pandini G, Vigneri R, Belfiore A (maio de 2012). "Proinsulin binds with high affinity the insulin receptor isoform A and predominantly activates the mitogenic pathway". Endocrinology 153 (5): 2152–63. PMID 22355074. doi:10.1210/en.2011-1843.

Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R (outubro de 2009). "Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease". Endocrine Reviews 30 (6): 586–623. PMID 19752219. doi:10.1210/er.2008-0047.

Knudsen L, De Meyts P, Kiselyov VV (decembro de 2011). "Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms" (PDF). The Biochemical Journal 440 (3): 397–403. PMID 21838706. doi:10.1042/BJ20110550.

Smith BJ, Huang K, Kong G, Chan SJ, Nakagawa S, Menting JG, Hu SQ, Whittaker J, Steiner DF, Katsoyannis PG, Ward CW, Weiss MA, Lawrence MC (abril de 2010). "Structural resolution of a tandem hormone-binding element in the insulin receptor and its implications for design of peptide agonists". Proceedings of the National Academy of Sciences of the United States of America 107 (15): 6771–6. Bibcode:2010PNAS..107.6771S. PMC 2872410. PMID 20348418. doi:10.1073/pnas.1001813107.

McKern NM, Lawrence MC, Streltsov VA, Lou MZ, Adams TE, Lovrecz GO, Elleman TC, Richards KM, Bentley JD, Pilling PA, Hoyne PA, Cartledge KA, Pham TM, Lewis JL, Sankovich SE, Stoichevska V, Da Silva E, Robinson CP, Frenkel MJ, Sparrow LG, Fernley RT, Epa VC, Ward CW (setembro de 2006). "Structure of the insulin receptor ectodomain reveals a folded-over conformation". Nature 443 (7108): 218–21. Bibcode:2006Natur.443..218M. PMID 16957736. doi:10.1038/nature05106.

Gutmann T, Kim KH, Grzybek M, Walz T, Coskun Ü (maio de 2018). "Visualization of ligand-induced transmembrane signaling in the full-length human insulin receptor". The Journal of Cell Biology 217 (5): 1643–1649. PMC 5940312. PMID 29453311. doi:10.1083/jcb.201711047.

Gutmann T, Schäfer IB, Poojari C, Brankatschk B, Vattulainen I, Strauss M, Coskun Ü (xaneiro de 2020). "Cryo-EM structure of the complete and ligand-saturated insulin receptor ectodomain". The Journal of Cell Biology 219 (1). PMC 7039211. PMID 31727777. doi:10.1083/jcb.201907210.

Kiselyov VV, Versteyhe S, Gauguin L, De Meyts P (febreiro de 2009). "Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation". Molecular Systems Biology 5 (5): 243. PMC 2657531. PMID 19225456. doi:10.1038/msb.2008.78.

de Meyts P, Roth J, Neville DM, Gavin JR, Lesniak MA (novembro de 1973). "Insulin interactions with its receptors: experimental evidence for negative cooperativity". Biochemical and Biophysical Research Communications 55 (1): 154–61. PMID 4361269. doi:10.1016/S0006-291X(73)80072-5.

Kumar L, Vizgaudis W, Klein-Seetharaman J (xullo de 2022). "Structure-based survey of ligand binding in the human insulin receptor". Br J Pharmacol 179 (14): 3512–3528. PMID 34907529. doi:10.1111/bph.15777.

Duckworth WC, Bennett RG, Hamel FG (outubro de 1998). "Insulin degradation: progress and potential". Endocrine Reviews 19 (5): 608–24. PMID 9793760. doi:10.1210/edrv.19.5.0349.

Tsai S, Clemente-Casares X, Zhou AC, Lei H, Ahn JJ, Chan YT, et al. (agosto de 2018). "Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection". Cell Metabolism 28 (6): 922–934.e4. PMID 30174303. doi:10.1016/j.cmet.2018.08.003.

Fischer HJ, Sie C, Schumann E, Witte AK, Dressel R, van den Brandt J, Reichardt HM (marzo de 2017). "The Insulin Receptor Plays a Critical Role in T Cell Function and Adaptive Immunity". Journal of Immunology 198 (5): 1910–1920. PMID 28115529. doi:10.4049/jimmunol.1601011.

Longo N, Wang Y, Smith SA, Langley SD, DiMeglio LA, Giannella-Neto D (xuño de 2002). "Genotype-phenotype correlation in inherited severe insulin resistance". Human Molecular Genetics 11 (12): 1465–75. PMID 12023989. doi:10.1093/hmg/11.12.1465.

Melvin A, Stears A (2017). "Severe insulin resistance: pathologies". Practical Diabetes (en inglés) 34 (6): 189–194a. doi:10.1002/pdi.2116. Consultado o 2020-10-31.

Maddux BA, Goldfine ID (xaneiro de 2000). "Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit". Diabetes 49 (1): 13–9. PMID 10615944. doi:10.2337/diabetes.49.1.13.

Langlais P, Dong LQ, Hu D, Liu F (xuño de 2000). "Identification of Grb10 as a direct substrate for members of the Src tyrosine kinase family". Oncogene 19 (25): 2895–903. PMID 10871840. doi:10.1038/sj.onc.1203616.

Hansen H, Svensson U, Zhu J, Laviola L, Giorgino F, Wolf G, Smith RJ, Riedel H (abril de 1996). "Interaction between the Grb10 SH2 domain and the insulin receptor carboxyl terminus". The Journal of Biological Chemistry 271 (15): 8882–6. PMID 8621530. doi:10.1074/jbc.271.15.8882.

Liu F, Roth RA (outubro de 1995). "Grb-IR: a SH2-domain-containing protein that binds to the insulin receptor and inhibits its function". Proceedings of the National Academy of Sciences of the United States of America 92 (22): 10287–91. Bibcode:1995PNAS...9210287L. PMC 40781. PMID 7479769. doi:10.1073/pnas.92.22.10287.

He W, Rose DW, Olefsky JM, Gustafson TA (marzo de 1998). "Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains". The Journal of Biological Chemistry 273 (12): 6860–7. PMID 9506989. doi:10.1074/jbc.273.12.6860.

Frantz JD, Giorgetti-Peraldi S, Ottinger EA, Shoelson SE (xaneiro de 1997). "Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains". The Journal of Biological Chemistry 272 (5): 2659–67. PMID 9006901. doi:10.1074/jbc.272.5.2659.

Kasus-Jacobi A, Béréziat V, Perdereau D, Girard J, Burnol AF (abril de 2000). "Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2". Oncogene 19 (16): 2052–9. PMID 10803466. doi:10.1038/sj.onc.1203469.

Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF (xaneiro de 2002). "Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action". The Journal of Biological Chemistry 277 (2): 1531–7. PMID 11606564. doi:10.1074/jbc.M101521200.

Sawka-Verhelle D, Tartare-Deckert S, White MF, Van Obberghen E (marzo de 1996). "Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786". The Journal of Biological Chemistry 271 (11): 5980–3. PMID 8626379. doi:10.1074/jbc.271.11.5980.

O'Neill TJ, Zhu Y, Gustafson TA (abril de 1997). "Interaction of MAD2 with the carboxyl terminus of the insulin receptor but not with the IGFIR. Evidence for release from the insulin receptor after activation". The Journal of Biological Chemistry 272 (15): 10035–40. PMID 9092546. doi:10.1074/jbc.272.15.10035.

Braiman L, Alt A, Kuroki T, Ohba M, Bak A, Tennenbaum T, Sampson SR (abril de 2001). "Insulin induces specific interaction between insulin receptor and protein kinase C delta in primary cultured skeletal muscle". Molecular Endocrinology 15 (4): 565–74. PMID 11266508. doi:10.1210/mend.15.4.0612.

Rosenzweig T, Braiman L, Bak A, Alt A, Kuroki T, Sampson SR (xuño de 2002). "Differential effects of tumor necrosis factor-alpha on protein kinase C isoforms alpha and delta mediate inhibition of insulin receptor signaling". Diabetes 51 (6): 1921–30. PMID 12031982. doi:10.2337/diabetes.51.6.1921.

Maegawa H, Ugi S, Adachi M, Hinoda Y, Kikkawa R, Yachi A, Shigeta Y, Kashiwagi A (marzo de 1994). "Insulin receptor kinase phosphorylates protein tyrosine phosphatase containing Src homology 2 regions and modulates its PTPase activity in vitro". Biochemical and Biophysical Research Communications 199 (2): 780–5. PMID 8135823. doi:10.1006/bbrc.1994.1297.

Kharitonenkov A, Schnekenburger J, Chen Z, Knyazev P, Ali S, Zwick E, White M, Ullrich A (decembro de 1995). "Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction". The Journal of Biological Chemistry 270 (49): 29189–93. PMID 7493946. doi:10.1074/jbc.270.49.29189.

Kotani K, Wilden P, Pillay TS (outubro de 1998). "SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase". The Biochemical Journal 335 (1): 103–9. PMC 1219757. PMID 9742218. doi:10.1042/bj3350103.

Nelms K, O'Neill TJ, Li S, Hubbard SR, Gustafson TA, Paul WE (decembro de 1999). "Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain". Mammalian Genome 10 (12): 1160–7. PMID 10594240. doi:10.1007/s003359901183.

harvard.edu

adsabs.harvard.edu

nih.gov

ncbi.nlm.nih.gov

Duckworth WC, Bennett RG, Hamel FG (outubro de 1998). "Insulin degradation: progress and potential". Endocrine Reviews 19 (5): 608–24. PMID 9793760. doi:10.1210/edrv.19.5.0349.

Receptor da insulina (Galician Wikipedia)

archive.org

archives-ouvertes.fr

hal.archives-ouvertes.fr

doi.org

dx.doi.org

harvard.edu

adsabs.harvard.edu

nih.gov

ncbi.nlm.nih.gov

practicaldiabetes.com

semanticscholar.org

zenodo.org